Changzhou Qianhong Bio-pharma starts construction of $145M biologics plant in Changzhou

Changzhou Qianhong Bio-pharma has started construction of the second phase of its manufacturing plant in Changzhou National Hi-Tech District, investing ¥1 billion ($145 million). The facility will produce innovative biologic drugs, adding 200 million tablets and 60 million injections annually.

“Changzhou Qianhong Bio-pharma, Tuesday announced it has started construction of the ¥1 billion ($145 million) project in the Changzhou National Hi-Tech District.”fiercepharma.com

• 1 source
• fiercepharma.comChinese drugmaker pours $145M into plant with plan to produce innovative biologics | Fierce PharmaEric PalmerDec 5, 2018

Summarized from public sources; check the original articles before acting on it.